ECA vs E-Document Explanation
Embodied Conversational Agent as Consent Advocate Compared to E-Consent Administration
2 other identifiers
interventional
35
1 country
1
Brief Summary
This study will investigate how consent forms and other health care documents are explained to patients. The findings will be used to create a computer program that can successfully explain consent and other health-related forms to individuals who have difficulty reading and understanding consent forms on their own as a supplement to the normal consent process done in research settings. In a prior study, the investigators delivered a similar protocol, where subjects were first consented and then given a mock consent form (administered in 1 of 3 arms: RA, ECA, or ECA + RA). Subjects in this protocol struggled with the concept of a "mock" consent process, especially after they had just completed a consent process for the study itself. The current protocol, using deception research methods, aims to provide a more pure assessment of ECA consent vs the standard (here, E-consent) by waiving consent and delivering the sham consent as if it were reality. In the context of a protocol that employs deception methods, participants in the current study would be invited as healthy volunteers, and be randomized to 1 of 2 different consent processes to evaluate the relative benefits of different approaches for informed consent. After the knowledge tests have been completed, subjects will undergo a debriefing where they are made fully aware of the deception and its purpose. At that time, subjects will also be given the opportunity to "opt out" and not have their data included in the study results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2017
CompletedFirst Posted
Study publicly available on registry
December 22, 2017
CompletedStudy Start
First participant enrolled
January 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 18, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2018
CompletedJuly 12, 2018
July 1, 2018
3 months
December 6, 2017
July 11, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Knowledge of informed consent document
A knowledge test will be given to assess the subjects' level of comprehension of the informed consent form
immediately following the study interview
Secondary Outcomes (2)
Survey of level of satisfaction with the ECA
immediately following the study interview
Amount of time spent on consent process
immediately following the study interview
Study Arms (2)
E-Consent
NO INTERVENTIONThis arm is the standard of care, where the consent form is presented to the subject on a computer screen and he/she can scroll ahead and back as needed. There is also an option to have each screen read aloud.
ECA Consent
EXPERIMENTALIn this arm an Embodied Conversational Agent (ECA) which is a computer generated character reads the consent form aloud to the subject, and also describes each section using a pre-loaded script. In addition, the character performs "teach-back", where she asks the subject a question about the section that was just described, and then repeats the section if the question is answered incorrectly.
Interventions
The Embodied Conversational Agent (ECA) is a computer generated character that can interact with study subjects through a touch screen computer. The ECA is programmed to respond with relevant speech and body language to a subject's responses.
Eligibility Criteria
You may qualify if:
- English speaking
- able to come in for a single study visit
You may not qualify if:
- Deaf
- Blind
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Medical Centerlead
- Northeastern Universitycollaborator
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Boston Medical Center
Boston, Massachusetts, 02118, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Paasche-Orlow, MD, MPH
Boston Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Dept General Internal Medicine, BUSM
Study Record Dates
First Submitted
December 6, 2017
First Posted
December 22, 2017
Study Start
January 4, 2018
Primary Completion
April 18, 2018
Study Completion
April 18, 2018
Last Updated
July 12, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share